Cargando…

Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures

BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant causes of liver-associated morbidity and mortality for millions of people globally. Ethiopia is one of the viral hepatitis–endemic countries with no national strategy for surveillance and limited data. As such, this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Beykaso, Gizachew, Mulu, Andargachew, Giday, Mirutse, Berhe, Nega, Selamu, Markos, Mihret, Adane, Teklehaymanot, Tilahun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646867/
https://www.ncbi.nlm.nih.gov/pubmed/34880693
http://dx.doi.org/10.2147/RMHP.S336776
_version_ 1784610520974753792
author Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Mihret, Adane
Teklehaymanot, Tilahun
author_facet Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Mihret, Adane
Teklehaymanot, Tilahun
author_sort Beykaso, Gizachew
collection PubMed
description BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant causes of liver-associated morbidity and mortality for millions of people globally. Ethiopia is one of the viral hepatitis–endemic countries with no national strategy for surveillance and limited data. As such, this study aimed to investigated the extent and associated risk factors of HBV and HCV among community members in southern Ethiopia. METHODS: A community-based cross-sectional study was conducted from January 2020 to August 2020. A structured questionnaire was used to collect behavioral and sociodemographic data. Serum samples were collected and assayed for seromarkers of HBV (HBsAg, anti-HBc, and anti-HBs) and HCV (anti-HCV) using ELISAs. In HBsAg-positive samples, HBV DNA was further quantified using RT-PCR. Data were entered into EpiData 3.1 and analyzed using SPSS 21.0. Descriptive statistics and logistic regression analysis were employed. RESULTS: The study included 693 participants. Seromarkers for HBsAg, anti-HCV, anti-HBc, and anti-HBs were found to be 9.5%, 1.4%, 31.1%, and 14.3%, respectively. In 66 HBsAg positives, 57 (86.4%) had quantifiable HBV DNA. Prevalence of current HBV infection (HBsAg(+), anti-HBc(+), anti-HBs(–)) and lifetime exposure (positive for either HBsAg or anti-HBc) to HBV were 8.7% and 31.9%, respectively, and 63.1% of participants were vulnerable or had no evidence of prior HBV infection (HBsAg(–), anti-HBc(–), anti-HBs(–)). On multivariate logistic regression analysis, multiple sexual contacts, family history of hepatitis infection, alcohol consumption, and khat chewing were significantly associated with HBV. The seroprevalence of HBV was relatively high in this study area. CONCLUSION: This study showed high prevalence of HBV infection, but low prevalence of HCV. This indicates that HBV is a major health problem in this community. Population-based surveillance, care, and treatment, as well as behavioral change and education programs, should be enhanced to minimize risk exposure.
format Online
Article
Text
id pubmed-8646867
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86468672021-12-07 Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures Beykaso, Gizachew Mulu, Andargachew Giday, Mirutse Berhe, Nega Selamu, Markos Mihret, Adane Teklehaymanot, Tilahun Risk Manag Healthc Policy Original Research BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant causes of liver-associated morbidity and mortality for millions of people globally. Ethiopia is one of the viral hepatitis–endemic countries with no national strategy for surveillance and limited data. As such, this study aimed to investigated the extent and associated risk factors of HBV and HCV among community members in southern Ethiopia. METHODS: A community-based cross-sectional study was conducted from January 2020 to August 2020. A structured questionnaire was used to collect behavioral and sociodemographic data. Serum samples were collected and assayed for seromarkers of HBV (HBsAg, anti-HBc, and anti-HBs) and HCV (anti-HCV) using ELISAs. In HBsAg-positive samples, HBV DNA was further quantified using RT-PCR. Data were entered into EpiData 3.1 and analyzed using SPSS 21.0. Descriptive statistics and logistic regression analysis were employed. RESULTS: The study included 693 participants. Seromarkers for HBsAg, anti-HCV, anti-HBc, and anti-HBs were found to be 9.5%, 1.4%, 31.1%, and 14.3%, respectively. In 66 HBsAg positives, 57 (86.4%) had quantifiable HBV DNA. Prevalence of current HBV infection (HBsAg(+), anti-HBc(+), anti-HBs(–)) and lifetime exposure (positive for either HBsAg or anti-HBc) to HBV were 8.7% and 31.9%, respectively, and 63.1% of participants were vulnerable or had no evidence of prior HBV infection (HBsAg(–), anti-HBc(–), anti-HBs(–)). On multivariate logistic regression analysis, multiple sexual contacts, family history of hepatitis infection, alcohol consumption, and khat chewing were significantly associated with HBV. The seroprevalence of HBV was relatively high in this study area. CONCLUSION: This study showed high prevalence of HBV infection, but low prevalence of HCV. This indicates that HBV is a major health problem in this community. Population-based surveillance, care, and treatment, as well as behavioral change and education programs, should be enhanced to minimize risk exposure. Dove 2021-12-01 /pmc/articles/PMC8646867/ /pubmed/34880693 http://dx.doi.org/10.2147/RMHP.S336776 Text en © 2021 Beykaso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Beykaso, Gizachew
Mulu, Andargachew
Giday, Mirutse
Berhe, Nega
Selamu, Markos
Mihret, Adane
Teklehaymanot, Tilahun
Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title_full Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title_fullStr Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title_full_unstemmed Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title_short Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures
title_sort burden and transmission risks of viral hepatitis in southern ethiopia: evidence needed for prevention and control measures
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646867/
https://www.ncbi.nlm.nih.gov/pubmed/34880693
http://dx.doi.org/10.2147/RMHP.S336776
work_keys_str_mv AT beykasogizachew burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT muluandargachew burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT gidaymirutse burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT berhenega burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT selamumarkos burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT mihretadane burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures
AT teklehaymanottilahun burdenandtransmissionrisksofviralhepatitisinsouthernethiopiaevidenceneededforpreventionandcontrolmeasures